Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 195

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 195
---
 may be forced to later write -downor write -offassets, restructure operations, or incur impairment or other charges that could result in losses. Even if NorthView’s due diligence successfully identifies certain risks, unexpected risks may arise, and previously known risks may materialize in a manner not consistent with NorthView’s preliminary risk analysis. If any of these risks materialize, this could have a material adverse effect on New Profusa’s financial condition and results of operations and could contribute to negative market perceptions about our securities or New Profusa. Accordingly, any of NorthView’s stockholders or warrant holders who choose to remain stockholders or warrant holders of New Profusa following the Business Combination could suffer a reduction in the value of their shares and warrants. Such stockholders or warrant holders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our directors or officers of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that the registration statement or proxy statement/prospectus relating to the Business Combination contained an actionable material misstatement or material omission. A market for NorthView’s securities may not continue, which would adversely affect the liquidity and price of NorthView’s securities. NorthView is currently a blank check company and there has not been a public market for shares of Profusa common stock since it is a private company. Following the Business Combination, the price of NorthView’s securities may fluctuate significantly due to the market’s reaction to the Business Combination and general market and economic conditions. An active trading market for NorthView’s securities following the Business Combination may never develop or, if developed, it may not be sustained. In addition, the price of NorthView’s securities after the Business Combination can vary due to general economic conditions and forecasts, NorthView’s general business condition and the release of NorthView’s financial reports. In the absence of a liquid public trading market: •you may not be able to liquidate your investment in shares of New Profusa Common Stock; •you may not be able to resell your shares of New Profusa Common Stock at or above the price attributed to them in the Business Combination; •the market price of shares of New Profusa Common Stock may experience significant price volatility; and •there may be less efficiency in carrying out your purchase and sale orders. Additionally, if NorthView’s securities become delisted from the Nasdaq for any reason, and are quoted on